Study reveals that preventing malaria in travelers to West Africa reduces health costs

September 23, 2013, Massachusetts General Hospital

Not only do U.S. travelers to West Africa who consult health providers before they leave and take prescribed preventive medications substantially reduce their risk of contracting malaria, they also reduce costs to their health insurance providers and, in most cases, to themselves. In a report that has been published online in Clinical Infectious Disease, researchers from the U.S. Centers for Disease Control and Prevention (CDC) and from Massachusetts General Hospital (MGH) report finding that the costs associated with contracting malaria—to both third-party payers and to individual travelers—outweigh the costs of preventive care.

"This analysis confirmed that pretravel health consultations for travelers going to areas where the risk of malaria is equivalent to that of West Africa result in cost-savings," says Edward Ryan, MD, director of the Tropical and Geographic Medicine Center in the MGH Division of Infectious Diseases, a co-author of the report and senior advisor for the research team. "We know from other studies that reduce the risk of contracting malaria, so the question we were looking at was whether for travelers saves money. The answer to the question is a resounding yes for health care insurers and carriers and, in many cases, for travelers themselves."

As part of its mission to prevent and track diseases in the U.S. and around the world, the CDC established the Global Travel Epidemiology Network (GTEN), a national network of travel clinics that collects data from individuals planning to travel internationally. Coordinated from the MGH Division of Infectious Diseases, GTEN now includes 26 clinical sites, 18 of which provided data for the current study. Although the CDC recommends that all consult with a health provider before their departure, most do not for reasons that can include lack of awareness or concern about health risks and the fact that pretravel appointments, vaccinations and preventive medications often are not covered by health insurance.

Since malaria prevention would be a major concern for travelers to areas of the world where the mosquito-borne illness is common, the current study used prevention of malaria in travelers to West Africa as a test case to examine the impact of pretravel consultation on health care expenditures. The research team compiled data collected in GTEN clinics from about 1,000 travelers going to countries in West Africa in 2009 and 2010—including how long they were traveling, the purpose of their trip and what anti-malarial drugs were prescribed.

This data was used by the CDC researchers—led by Kenji Adachi, PhD, and Margaret S. Coleman, PhD—to construct the economic model analyzing the costs and benefits of the pretravel consultation. For travelers, preventive costs included any co-pays for the appointment, time off from work and costs of prescribed medication. These were compared—from perspectives of both travelers and coverage providers—with the costs that would be incurred if a traveler contracted malaria, which usually include hospitalization, sometimes in intensive care.

Depending on factors such as the length of a trip—which affects both the risk of contracting malaria and the costs of preventive medication—and the costs and effectiveness of the prescribed drugs, the model revealed that, while the costs to payers for preventive services ranged from $161 to $208, the average costs to treat a case of malaria would be more than $25,000. Overall the analysis found that covering preventive services could save payers from $14 to $371 per patient, with greater savings associated with longer visits to malaria-prone areas. For individual travelers, while out-of-pocket costs for prevention averaged around $45, contracting malaria would cost an average of nearly $3,400. Travelers staying less than 9 days, whose risk of contracting malaria would be considered low, would have a net cost of around $20, but those staying a month or longer would save an average of $32.

Ryan, a professor of Medicine at Harvard Medical School, explains, "We focused this analysis on one illness, malaria, but pre-travel medical care also involves trying to prevent many other illnesses associated with travel. Our analysis suggests that, not only does it make good medical sense for travelers to check in with their provider before traveling, it also makes solid economic sense. In this era of trying to maximize the utility of every -care dollar, studies such as this will play a critical role."

Explore further: New study finds malaria, typhoid—not Ebola—biggest health threat for travelers to tropics

Related Stories

New study finds malaria, typhoid—not Ebola—biggest health threat for travelers to tropics

January 16, 2013
Feeling feverish after a visit to the tropics? It may not just be a bout with this year's flu. If you're a Western traveler, malaria and typhoid fever should top the list of diseases to discuss with your doctor when you return, ...

Study estimates costs of health-care-associated infections

September 2, 2013
A study estimates that total annual costs for five major health care-associated infections (HAIs) were $9.8 billion, with surgical site infections contributing the most to overall costs, according to a report published by ...

New WHO test-based approach against malaria does not work everywhere

July 1, 2013
In view of the sharp rise in treatment costs of malaria, the World Health Organization (WHO) says that there must be a hard diagnosis before the disease is treated. The WHO is deploying rapid tests, a variation of the well-known ...

Recommended for you

Past encounters with the flu shape vaccine response

February 20, 2018
New research on why the influenza vaccine was only modestly effective in recent years shows that immune history with the flu influences a person's response to the vaccine.

Building better tiny kidneys to test drugs and help people avoid dialysis

February 16, 2018
A free online kidney atlas built by USC researchers empowers stem cell scientists everywhere to generate more human-like tiny kidneys for testing new drugs and creating renal replacement therapies.

Expanding Hepatitis C testing to all adults is cost-effective and improves outcomes

February 16, 2018
According to a new study, screening all adults for hepatitis C (HCV) is a cost-effective way to improve clinical outcomes of HCV and identify more infected people compared to current recommendations. Using a simulation model, ...

Study suggests expanded range for emerging tick-borne disease

February 16, 2018
Human cases of Borrelia miyamotoi, a tick-borne infection with some similarities to Lyme disease, were discovered in the eastern United States less than a decade ago. Now new research led by the Yale School of Public Health ...

IFN-mediated immunity to influenza A virus infection influenced by RIPK3 protein

February 15, 2018
Each year, influenza kills half a million people globally with the elderly and very young most often the victims. In fact, the Centers for Disease Control and Prevention reported 37 children have died in the United States ...

Flu shot only 36 percent effective, making bad year worse (Update)

February 15, 2018
The flu vaccine is doing a poor job protecting older Americans and others against the bug that's causing most illnesses.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.